$4450
$3560
The Point of Care Diagnostics Market size is projected to reach US$ 88.83 billion by 2031 from US$ 37.93 billion in 2024. The market is estimated to register a CAGR of 13.0% during 2024–2031. The Integration Of Artificial Intelligence (AI) and Machine Learning (ML) is likely to bring new trends to the market in the coming years.
Point of Care Diagnostics Market Analysis
The Point of Care (POC) Diagnostics Market growth is driven by the increasing prevalence of infectious diseases, which has heightened the demand for rapid and accurate diagnostic solutions. Technological advancements and the integration of artificial intelligence and machine learning are enhancing the efficiency and accuracy of testing methods. Additionally, the growing need for self-diagnostic tools and the shift toward decentralized healthcare are expected to create future opportunities for market expansion. However, challenges such as the standardization between POC testing and centralized laboratory methods impact the broader adoption of these diagnostic solutions.
Point of Care Diagnostics Market Overview
The Point of Care (POC) Diagnostics Market is evolving, with the increasing demand for immediate and accurate diagnostic solutions. POC testing is conducted near the site of patient care, allowing for quick results that facilitate timely decision-making in clinical settings. This demand for this testing is influenced by the rising prevalence of infectious diseases and chronic conditions, which necessitate rapid diagnostic capabilities.
Innovations such as portable diagnostic devices and integrated digital health solutions enhance testing efficiency and accessibility. The shift toward decentralized healthcare models propels patients and healthcare providers to seek more convenient testing options that can be performed outside traditional laboratory settings.
Overall, the POC diagnostics market is poised for substantial growth, driven by the need for rapid testing solutions and the ongoing advancements in diagnostic technologies.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Point of Care Diagnostics Market: Strategic Insights
Market Size Value in US$ 36,000.4 Million in 2021 Market Size Value by US$ 82,958.3 Million by 2028 Growth rate CAGR of 12.7% from 2021-2028 Forecast Period 2021-2028 Base Year 2021
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Point of Care Diagnostics Market: Strategic Insights

Market Size Value in | US$ 36,000.4 Million in 2021 |
Market Size Value by | US$ 82,958.3 Million by 2028 |
Growth rate | CAGR of 12.7% from 2021-2028 |
Forecast Period | 2021-2028 |
Base Year | 2021 |

Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Point of Care Diagnostics Market Drivers and Opportunities
Key Product Launches and Developments
The number of point-of-care tests has increased since its introduction. It is expected to grow with new product launches intended at delivering inexpensive care at the facilities at the closest possible distance from the patients' location. New products or technologies are being introduced to enhance the effectiveness of devices with incremental improvements in analytical performance. The growth of the point of care diagnostics market is driven by the introduction of new devices to perform molecular tests. New devices launched in the recent years include:
• In June 2023, Sysmex Corporation launched a point-of-care testing system in Europe to detect antimicrobial susceptibility. The system identifies the presence or absence of bacteria and evaluates the effectiveness of antimicrobials using patient urine samples suspected of having UTIs.
• In January 2023, Cipla Limited launched Cippoint, a point-of-care testing device. This device provides testing parameters such as cardiac markers, infectious diseases, diabetes, fertility, thyroid function, inflammation, metabolic markers, and coagulation markers. The device is CE IVD approved, which indicates that the device is approved by the European In-Vitro Diagnostic Device Directive, providing reliable testing solutions.
• In July 2021, QuantuMDx launched the Q-POC rapid PCR point-of-care diagnostic system, with its first test, a SARS-CoV-2 detection assay, now CE-IVD marked for use in Europe under the In Vitro Diagnostics Directive (98/79/EC).
Thus, increasing product launches by the market players propels the growth of the POC diagnostics market.
Rising Product Launches and Advancements by Market Players in Emerging Economies
For business expansion, market players are focusing on emerging nations, such as India, China, and Brazil, due to the large population suffering from HIV and other infectious diseases. According to the Press Information Bureau 2023 report, ~2.5 million people are living with HIV in India, with a prevalence rate of 0.2%, and 66,400 new HIV infections are reported in India annually. The increasing product launches indicate a potential environment for the adoption of advanced point-of-care diagnostic kits. In January 2022, Mylab launched the CoviSwift POC testing solution in India, which can be used in small labs, in-hospital labs, airports, and villages and allows gold-standard testing at high throughputs anywhere. The solution encompasses the CoviSwift assay and Compact-Q machines that process 16 samples within 40 minutes, which is approximately 4 times faster than traditional RT-PCR testing while maintaining high precision.
Advancements in nanotechnology and genomics are increasing the demand for diagnostics in the healthcare sector, encouraging the introduction of a greater number of point-of-care test systems and facilitating the shift toward personalized medicine. There are new opportunities in infectious disease testing, molecular oncology, and pharmacogenomics in emerging countries. The development of nanomaterials and nanotechnology has promoted the progress of POCT platforms, which are used in colorimetric, optical, electrochemical, magnetic, and catalytic approaches. The point of care testing platforms are used to detect nucleic acids, proteins, pesticides, viruses, bio-markers in disease diagnosis, and even heavy-metal species. Thus, rising product launches and advancements in emerging countries are anticipated to provide ample growth opportunities for the point-of-care diagnostics market during the forecast period.
Point of Care Diagnostics Market Report Segmentation Analysis
Key segments that contributed to the derivation of the Point of Care Diagnostics Market analysis are product, purchase mode, sample, end user, and geography.
- Based on product, the point of care diagnostics market is segmented into glucose monitoring, infectious disease testing, cardiometabolic testing, pregnancy and fertility testing, coagulation testing, tumor/cancer marker testing, cholesterol testing, urinalysis testing, hematology testing, thyroid testing, and others. The glucose monitoring segment held the largest share of the point of care diagnostics market in 2024, and it is expected to register a significant CAGR during 2024–2031.
- By purchase mode, the market is categorized into OTC and prescription. The prescription segment held a larger share of the point of care diagnostics market in 2024.
- As per sample, the point of care diagnostics market is segmented into blood, urine, and others. The blood segment held the largest share of the point of care diagnostics market in 2024, and it is expected to register a significant CAGR during 2024–2031.
- Per end user, the Point of Care Diagnostics Market is segmented into healthcare facilities, homecare, and others. The healthcare facilities segment held the largest share of the Point of Care Diagnostics Market in 2024, and it is expected to register a significant CAGR during 2024–2031.
Point of Care Diagnostics Market Share Analysis by Geography
The geographic scope of the Point of Care Diagnostics Market report is mainly divided into five major regions: North America, Europe, Asia Pacific, the Middle East and Africa, and South and Central America. North America region is leading the market due to its robust healthcare infrastructure and early adoption of innovative diagnostic technologies. Canada ranks eighth among the largest medical device markets. According to the Government of Canada 2023 report, the prevalence of diabetes is rising at a significant pace. ~3.7 million population of the country (which is 9.4% of the total population) are living with diabetes or prediabetic conditions. The association has stated that every three minutes, a person is diagnosed with diabetes. Additionally, according to a report published by the government of Canada, the prevalence of HIV in Canada has grown by ~35.2% since 2022, and 2,434 new HIV cases reported in 2023. As per the Canadian Cancer Society, cancer was one of the primary reasons for deaths in the country, as the condition caused ~30% of deaths in 2023. Lung, breast, colorectal, and prostate cancer conditions predominated the diagnoses and deaths, with more than 46% share.
In July 2023, Fortis Life Sciences, LLC acquired Toronto-based International Point of Care, Inc. (IPOC). IPOC develops and manufactures components used in diagnostics, including lyophilized reagents, membranes, recombinant proteins, and controls. With this acquisition, Fortis can provide its customers with a customizable, end-to-end solution to advance their immunodiagnostic and molecular diagnostic products. IPOC’s recently expanded 36,000 sq. ft. facility is Fortis’ third GMP and ISO 13485-compliant manufacturing site in North America. Thus, the surging prevalence of cancer, the rising incidence of other diseases, and strategic collaborations fuel the growth of the point of care diagnostics market in the country.
Digital PCR and Real-Time PCR Market Report Scope
Point of Care Diagnostics Market News and Recent Developments
The Point of Care Diagnostics Market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the key developments in the market are listed below:
- bioMérieux, a leader in the field of in vitro diagnostics, announced that it has entered into an agreement to acquire SpinChip Diagnostics ASA (“SpinChip”). This privately held Norwegian diagnostics company has developed a game-changing immunoassay diagnostics platform. The small benchtop analyzer is adapted to near patient testing as it can deliver a result from a whole blood sample within 10 minutes with the same high-sensitivity performance as the laboratory instruments. bioMérieux has held a minority stake in SpinChip since March 2024. (Source: bioMérieux, Company Website, January 2025)
- Roche announced the completion of the acquisition of LumiraDx’s Point of Care technology following the receipt of all required antitrust and regulatory clearances. Roche will now integrate the company’s multi-assay point of care platform and the related R&D, operational, and commercial sites into its global organization. (Source: Roche, Company Website, July 2024).
Point of Care Diagnostics Market Report Coverage and Deliverables
The "Point of Care Diagnostics Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:
- Point of Care Diagnostics Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Point of Care Diagnostics Market trends, as well as market dynamics such as drivers, restraints, and key opportunities
- Detailed PEST and SWOT analysis
- Digital PCR and real-time PCR market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the digital PCR and real-time PCR market
- Detailed company profiles

Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Product , Prescription Mode , and End User , and Geography

Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
The market value is expected to reach US$ 88.83 billion by 2031.
BD, Abbott, Johnson and Johnson Services, Inc., F. HOFFMANN-LA ROCHE LTD, Siemens AG, Danaher, BIO-RAD LABORATORIES INC, BioMerieux SA, Polymer Technology Systems, Inc. (PTS), Nova Biomedical are key players in the market.
Integration of artificial intelligence (AI) and machine learning (ML) is expected to be a prime trend in the market in the coming years.
The increasing prevalence of infectious diseases and key product launches and developments fuel the market growth.
North America dominated the market in 2024.
The market is expected to register a CAGR of 13.0% during 2024–2031.
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Analyst Market Outlook
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. Point of Care Diagnostics Market Landscape
4.1 Overview
4.2 PEST Analysis
5. Point of Care Diagnostics Market – Key Market Dynamics
5.1 Point of Care Diagnostics Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Increasing Prevalence of Infectious Diseases
5.2.2 Key Product Launches and Developments
5.3 Market Restraints
5.3.1 Product Recalls
5.4 Market Opportunities
5.4.1 Rising Product Launches and Advancements by Market Players in Emerging Economies
5.5 Future Trends
5.5.1 Integration Of Artificial Intelligence (AI) and Machine Learning (ML)
5.6 Impact of Drivers and Restraints:
6. Point of Care Diagnostics Market – Global Market Analysis
6.1 Point of Care Diagnostics Market Revenue (US$ Million), 2021–2031
6.2 Point of Care Diagnostics Market Forecast Analysis
7. Point of Care Diagnostics Market Analysis – by Product
7.1 Glucose Monitoring
7.1.1 Overview
7.1.2 Glucose Monitoring: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Infectious Disease Testing
7.2.1 Overview
7.2.2 Infectious Disease Testing: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Cardio metabolic Testing
7.3.1 Overview
7.3.2 Cardio metabolic Testing: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Pregnancy And Fertility Testing
7.4.1 Overview
7.4.2 Pregnancy And Fertility Testing: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Coagulation Testing
7.5.1 Overview
7.5.2 Coagulation Testing: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.6 Tumor or Cancer Marker Testing
7.6.1 Overview
7.6.2 Tumor or Cancer Marker Testing: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.7 Cholesterol Testing
7.7.1 Overview
7.7.2 Cholesterol Testing: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.8 Urinalysis Testing
7.8.1 Overview
7.8.2 Urinalysis Testing: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.9 Hematology Testing
7.9.1 Overview
7.9.2 Hematology Testing: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.10 Thyroid Testing
7.10.1 Overview
7.10.2 Thyroid Testing: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.11 Others
7.11.1 Overview
7.11.2 Others: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
8. Point of Care Diagnostics Market Analysis – by Purchase Mode
8.1 OTC
8.1.1 Overview
8.1.2 OTC: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
8.2 Prescription
8.2.1 Overview
8.2.2 Prescription: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
9. Point of Care Diagnostics Market Analysis – by Sample
9.1 Blood
9.1.1 Overview
9.1.2 Blood: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
9.2 Urine
9.2.1 Overview
9.2.2 Urine: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
9.3 Others
9.3.1 Overview
9.3.2 Others: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
10. Point of Care Diagnostics Market Analysis – by End User
10.1 Healthcare Facilities
10.1.1 Overview
10.1.2 Healthcare Facilities: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
10.2 Homecare
10.2.1 Overview
10.2.2 Homecare: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
10.3 Others
10.3.1 Overview
10.3.2 Others: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
11. Point of Care Diagnostics Market – Geographical Analysis
11.1 Overview
11.2 North America
11.2.1 North America Point of Care Diagnostics Market Overview
11.2.2 North America: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)
11.2.3 North America: Point of Care Diagnostics Market Breakdown, by Product
11.2.3.1 North America: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Product
11.2.3.2 North America: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Glucose Monitoring
11.2.3.3 North America: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Infectious Disease Testing
11.2.3.4 North America: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Cardio Metabolic Testing
11.2.4 North America: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.2.4.1 North America: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Purchase Mode
11.2.5 North America: Point of Care Diagnostics Market Breakdown, by Sample
11.2.5.1 North America: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Sample
11.2.6 North America: Point of Care Diagnostics Market Breakdown, by End User
11.2.6.1 North America: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by End User
11.2.6.2 North America: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Healthcare Facilities
11.2.7 North America: Point of Care Diagnostics Market – Revenue and Forecast Analysis – by Country
11.2.7.1 North America: Point of Care Diagnostics Market – Revenue and Forecast Analysis – by Country
11.2.7.2 United States: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)
11.2.7.2.1 United States: Point of Care Diagnostics Market Breakdown, by Product
11.2.7.2.2 United States: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.2.7.2.3 United States: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.2.7.2.4 United States: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.2.7.2.5 United States: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.2.7.2.6 United States: Point of Care Diagnostics Market Breakdown, by Sample
11.2.7.2.7 United States: Point of Care Diagnostics Market Breakdown, by End User
11.2.7.2.8 United States: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.2.7.3 Canada: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)
11.2.7.3.1 Canada: Point of Care Diagnostics Market Breakdown, by Product
11.2.7.3.2 Canada: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.2.7.3.3 Canada: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.2.7.3.4 Canada: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.2.7.3.5 Canada: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.2.7.3.6 Canada: Point of Care Diagnostics Market Breakdown, by Sample
11.2.7.3.7 Canada: Point of Care Diagnostics Market Breakdown, by End User
11.2.7.3.8 Canada: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.2.7.4 Mexico: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)
11.2.7.4.1 Mexico: Point of Care Diagnostics Market Breakdown, by Product
11.2.7.4.2 Mexico: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.2.7.4.3 Mexico: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.2.7.4.4 Mexico: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.2.7.4.5 Mexico: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.2.7.4.6 Mexico: Point of Care Diagnostics Market Breakdown, by Sample
11.2.7.4.7 Mexico: Point of Care Diagnostics Market Breakdown, by End User
11.2.7.4.8 Mexico: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.3 Europe
11.3.1 EuropePoint of Care Diagnostics Market Overview
11.3.2 Europe: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)
11.3.3 Europe: Point of Care Diagnostics Market Breakdown, by Product
11.3.3.1 Europe: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Product
11.3.3.2 Europe: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Glucose Monitoring
11.3.3.3 Europe: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Infectious Disease Testing
11.3.3.4 Europe: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Cardio Metabolic Testing
11.3.4 Europe: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.3.4.1 Europe: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Purchase Mode
11.3.5 Europe: Point of Care Diagnostics Market Breakdown, by Sample
11.3.5.1 Europe: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Sample
11.3.6 Europe: Point of Care Diagnostics Market Breakdown, by End User
11.3.6.1 Europe: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by End User
11.3.6.2 Europe: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Healthcare Facilities
11.3.7 Europe: Point of Care Diagnostics Market – Revenue and Forecast Analysis – by Country
11.3.7.1 Europe: Point of Care Diagnostics Market – Revenue and Forecast Analysis – by Country
11.3.7.2 United Kingdom: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)
11.3.7.2.1 United Kingdom: Point of Care Diagnostics Market Breakdown, by Product
11.3.7.2.2 United Kingdom: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.3.7.2.3 United Kingdom: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.3.7.2.4 United Kingdom: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.3.7.2.5 United Kingdom: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.3.7.2.6 United Kingdom: Point of Care Diagnostics Market Breakdown, by Sample
11.3.7.2.7 United Kingdom: Point of Care Diagnostics Market Breakdown, by End User
11.3.7.2.8 United Kingdom: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.3.7.3 Germany: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)
11.3.7.3.1 Germany: Point of Care Diagnostics Market Breakdown, by Product
11.3.7.3.2 Germany: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.3.7.3.3 Germany: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.3.7.3.4 Germany: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.3.7.3.5 Germany: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.3.7.3.6 Germany: Point of Care Diagnostics Market Breakdown, by Sample
11.3.7.3.7 Germany: Point of Care Diagnostics Market Breakdown, by End User
11.3.7.3.8 Germany: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.3.7.4 France: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)
11.3.7.4.1 France: Point of Care Diagnostics Market Breakdown, by Product
11.3.7.4.2 France: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.3.7.4.3 France: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.3.7.4.4 France: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.3.7.4.5 France: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.3.7.4.6 France: Point of Care Diagnostics Market Breakdown, by Sample
11.3.7.4.7 France: Point of Care Diagnostics Market Breakdown, by End User
11.3.7.4.8 France: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.3.7.5 Italy: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)
11.3.7.5.1 Italy: Point of Care Diagnostics Market Breakdown, by Product
11.3.7.5.2 Italy: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.3.7.5.3 Italy: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.3.7.5.4 Italy: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.3.7.5.5 Italy: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.3.7.5.6 Italy: Point of Care Diagnostics Market Breakdown, by Sample
11.3.7.5.7 Italy: Point of Care Diagnostics Market Breakdown, by End User
11.3.7.5.8 Italy: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.3.7.6 Spain: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)
11.3.7.6.1 Spain: Point of Care Diagnostics Market Breakdown, by Product
11.3.7.6.2 Spain: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.3.7.6.3 Spain: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.3.7.6.4 Spain: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.3.7.6.5 Spain: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.3.7.6.6 Spain: Point of Care Diagnostics Market Breakdown, by Sample
11.3.7.6.7 Spain: Point of Care Diagnostics Market Breakdown, by End User
11.3.7.6.8 Spain: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.3.7.7 Rest of Europe: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)
11.3.7.7.1 Rest of Europe: Point of Care Diagnostics Market Breakdown, by Product
11.3.7.7.2 Rest of Europe: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.3.7.7.3 Rest of Europe: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.3.7.7.4 Rest of Europe: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.3.7.7.5 Rest of Europe: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.3.7.7.6 Rest of Europe: Point of Care Diagnostics Market Breakdown, by Sample
11.3.7.7.7 Rest of Europe: Point of Care Diagnostics Market Breakdown, by End User
11.3.7.7.8 Rest of Europe: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.4 Asia Pacific
11.4.1 Asia PacificPoint of Care Diagnostics Market Overview
11.4.2 Asia Pacific: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)
11.4.3 Asia Pacific: Point of Care Diagnostics Market Breakdown, by Product
11.4.3.1 Asia Pacific: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Product
11.4.3.2 Asia Pacific: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Glucose Monitoring
11.4.3.3 Asia Pacific: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Infectious Disease Testing
11.4.3.4 Asia Pacific: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Cardio Metabolic Testing
11.4.4 Asia Pacific: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.4.4.1 Asia Pacific: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Purchase Mode
11.4.5 Asia Pacific: Point of Care Diagnostics Market Breakdown, by Sample
11.4.5.1 Asia Pacific: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Sample
11.4.6 Asia Pacific: Point of Care Diagnostics Market Breakdown, by End User
11.4.6.1 Asia Pacific: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by End User
11.4.6.2 Asia Pacific: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Healthcare Facilities
11.4.7 Asia Pacific: Point of Care Diagnostics Market – Revenue and Forecast Analysis – by Country
11.4.7.1 Asia Pacific: Point of Care Diagnostics Market – Revenue and Forecast Analysis – by Country
11.4.7.2 China: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)
11.4.7.2.1 China: Point of Care Diagnostics Market Breakdown, by Product
11.4.7.2.2 China: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.4.7.2.3 China: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.4.7.2.4 China: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.4.7.2.5 China: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.4.7.2.6 China: Point of Care Diagnostics Market Breakdown, by Sample
11.4.7.2.7 China: Point of Care Diagnostics Market Breakdown, by End User
11.4.7.2.8 China: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.4.7.3 Japan: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)
11.4.7.3.1 Japan: Point of Care Diagnostics Market Breakdown, by Product
11.4.7.3.2 Japan: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.4.7.3.3 Japan: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.4.7.3.4 Japan: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.4.7.3.5 Japan: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.4.7.3.6 Japan: Point of Care Diagnostics Market Breakdown, by Sample
11.4.7.3.7 Japan: Point of Care Diagnostics Market Breakdown, by End User
11.4.7.3.8 Japan: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.4.7.4 India: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)
11.4.7.4.1 India: Point of Care Diagnostics Market Breakdown, by Product
11.4.7.4.2 India: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.4.7.4.3 India: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.4.7.4.4 India: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.4.7.4.5 India: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.4.7.4.6 India: Point of Care Diagnostics Market Breakdown, by Sample
11.4.7.4.7 India: Point of Care Diagnostics Market Breakdown, by End User
11.4.7.4.8 India: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.4.7.5 Australia: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)
11.4.7.5.1 Australia: Point of Care Diagnostics Market Breakdown, by Product
11.4.7.5.2 Australia: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.4.7.5.3 Australia: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.4.7.5.4 Australia: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.4.7.5.5 Australia: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.4.7.5.6 Australia: Point of Care Diagnostics Market Breakdown, by Sample
11.4.7.5.7 Australia: Point of Care Diagnostics Market Breakdown, by End User
11.4.7.5.8 Australia: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.4.7.6 South Korea: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)
11.4.7.6.1 South Korea: Point of Care Diagnostics Market Breakdown, by Product
11.4.7.6.2 South Korea: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.4.7.6.3 South Korea: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.4.7.6.4 South Korea: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.4.7.6.5 South Korea: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.4.7.6.6 South Korea: Point of Care Diagnostics Market Breakdown, by Sample
11.4.7.6.7 South Korea: Point of Care Diagnostics Market Breakdown, by End User
11.4.7.6.8 South Korea: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.4.7.7 Rest of APAC: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)
11.4.7.7.1 Rest of APAC: Point of Care Diagnostics Market Breakdown, by Product
11.4.7.7.2 Rest of APAC: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.4.7.7.3 Rest of APAC: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.4.7.7.4 Rest of APAC: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.4.7.7.5 Rest of APAC: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.4.7.7.6 Rest of APAC: Point of Care Diagnostics Market Breakdown, by Sample
11.4.7.7.7 Rest of APAC: Point of Care Diagnostics Market Breakdown, by End User
11.4.7.7.8 Rest of APAC: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.5 Middle East and Africa
11.5.1 Middle East and AfricaPoint of Care Diagnostics Market Overview
11.5.2 Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)
11.5.3 Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Product
11.5.3.1 Middle East and Africa: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Product
11.5.3.2 Middle East and Africa: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Glucose Monitoring
11.5.3.3 Middle East and Africa: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Infectious Disease Testing
11.5.3.4 Middle East and Africa: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Cardio Metabolic Testing
11.5.4 Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.5.4.1 Middle East and Africa: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Purchase Mode
11.5.5 Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Sample
11.5.5.1 Middle East and Africa: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Sample
11.5.6 Middle East and Africa: Point of Care Diagnostics Market Breakdown, by End User
11.5.6.1 Middle East and Africa: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by End User
11.5.6.2 Middle East and Africa: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Healthcare Facilities
11.5.7 Middle East and Africa: Point of Care Diagnostics Market – Revenue and Forecast Analysis – by Country
11.5.7.1 Middle East and Africa: Point of Care Diagnostics Market – Revenue and Forecast Analysis – by Country
11.5.7.2 South Africa: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)
11.5.7.2.1 South Africa: Point of Care Diagnostics Market Breakdown, by Product
11.5.7.2.2 South Africa: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.5.7.2.3 South Africa: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.5.7.2.4 South Africa: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.5.7.2.5 South Africa: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.5.7.2.6 South Africa: Point of Care Diagnostics Market Breakdown, by Sample
11.5.7.2.7 South Africa: Point of Care Diagnostics Market Breakdown, by End User
11.5.7.2.8 South Africa: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.5.7.3 Saudi Arabia: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)
11.5.7.3.1 Saudi Arabia: Point of Care Diagnostics Market Breakdown, by Product
11.5.7.3.2 Saudi Arabia: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.5.7.3.3 Saudi Arabia: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.5.7.3.4 Saudi Arabia: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.5.7.3.5 Saudi Arabia: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.5.7.3.6 Saudi Arabia: Point of Care Diagnostics Market Breakdown, by Sample
11.5.7.3.7 Saudi Arabia: Point of Care Diagnostics Market Breakdown, by End User
11.5.7.3.8 Saudi Arabia: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.5.7.4 United Arab Emirates: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)
11.5.7.4.1 United Arab Emirates: Point of Care Diagnostics Market Breakdown, by Product
11.5.7.4.2 United Arab Emirates: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.5.7.4.3 United Arab Emirates: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.5.7.4.4 United Arab Emirates: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.5.7.4.5 United Arab Emirates: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.5.7.4.6 United Arab Emirates: Point of Care Diagnostics Market Breakdown, by Sample
11.5.7.4.7 United Arab Emirates: Point of Care Diagnostics Market Breakdown, by End User
11.5.7.4.8 United Arab Emirates: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.5.7.5 Rest of Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)
11.5.7.5.1 Rest of Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Product
11.5.7.5.2 Rest of Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.5.7.5.3 Rest of Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.5.7.5.4 Rest of Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.5.7.5.5 Rest of Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.5.7.5.6 Rest of Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Sample
11.5.7.5.7 Rest of Middle East and Africa: Point of Care Diagnostics Market Breakdown, by End User
11.5.7.5.8 Rest of Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.6 South and Central America
11.6.1 South and Central America Point of Care Diagnostics Market Overview
11.6.2 South and Central America: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)
11.6.3 South and Central America: Point of Care Diagnostics Market Breakdown, by Product
11.6.3.1 South and Central America: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Product
11.6.3.2 South and Central America: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Glucose Monitoring
11.6.3.3 South and Central America: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Infectious Disease Testing
11.6.3.4 South and Central America: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Cardio Metabolic Testing
11.6.4 South and Central America: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.6.4.1 South and Central America: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Purchase Mode
11.6.5 South and Central America: Point of Care Diagnostics Market Breakdown, by Sample
11.6.5.1 South and Central America: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Sample
11.6.6 South and Central America: Point of Care Diagnostics Market Breakdown, by End User
11.6.6.1 South and Central America: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by End User
11.6.6.2 South and Central America: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Healthcare Facilities
11.6.7 South and Central America: Point of Care Diagnostics Market – Revenue and Forecast Analysis – by Country
11.6.7.1 South and Central America: Point of Care Diagnostics Market – Revenue and Forecast Analysis – by Country
11.6.7.2 Brazil: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)
11.6.7.2.1 Brazil: Point of Care Diagnostics Market Breakdown, by Product
11.6.7.2.2 Brazil: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.6.7.2.3 Brazil: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.6.7.2.4 Brazil: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.6.7.2.5 Brazil: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.6.7.2.6 Brazil: Point of Care Diagnostics Market Breakdown, by Sample
11.6.7.2.7 Brazil: Point of Care Diagnostics Market Breakdown, by End User
11.6.7.2.8 Brazil: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.6.7.3 Argentina: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)
11.6.7.3.1 Argentina: Point of Care Diagnostics Market Breakdown, by Product
11.6.7.3.2 Argentina: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.6.7.3.3 Argentina: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.6.7.3.4 Argentina: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.6.7.3.5 Argentina: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.6.7.3.6 Argentina: Point of Care Diagnostics Market Breakdown, by Sample
11.6.7.3.7 Argentina: Point of Care Diagnostics Market Breakdown, by End User
11.6.7.3.8 Argentina: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.6.7.4 Rest of South and Central America: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)
11.6.7.4.1 Rest of South and Central America: Point of Care Diagnostics Market Breakdown, by Product
11.6.7.4.2 Rest of South and Central America: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
11.6.7.4.3 Rest of South and Central America: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
11.6.7.4.4 Rest of South and Central America: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
11.6.7.4.5 Rest of South and Central America: Point of Care Diagnostics Market Breakdown, by Purchase Mode
11.6.7.4.6 Rest of South and Central America: Point of Care Diagnostics Market Breakdown, by Sample
11.6.7.4.7 Rest of South and Central America: Point of Care Diagnostics Market Breakdown, by End User
11.6.7.4.8 Rest of South and Central America: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
12. Competitive Landscape
12.1 Heat Map Analysis by Key Players
12.2 Company Market Share Analysis, 2024
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Merger and Acquisition
14. Company Profiles
14.1 F. Hoffmann-La Roche Ltd
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Beckman Coulter Inc
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Bio-Rad Laboratories Inc
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Abbott Laboratories
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Johnson & Johnson
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Siemens AG
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 BD
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 bioMerieux SA
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Polymer Technology Systems, Inc. (PTS)
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Nova Biomedical Corporation
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
14.11 Talis Biomedical Corporation
14.11.1 Key Facts
14.11.2 Business Description
14.11.3 Products and Services
14.11.4 Financial Overview
14.11.5 SWOT Analysis
14.11.6 Key Developments
14.12 QuidelOrtho Corp
14.12.1 Key Facts
14.12.2 Business Description
14.12.3 Products and Services
14.12.4 Financial Overview
14.12.5 SWOT Analysis
14.12.6 Key Developments
14.13 Chembio Diagnostics, Inc.
14.13.1 Key Facts
14.13.2 Business Description
14.13.3 Products and Services
14.13.4 Financial Overview
14.13.5 SWOT Analysis
14.13.6 Key Developments
15. Appendix
15.1 About The Insight Partners
List of Tables
Table 1. Point of Care Diagnostics Market Segmentation
Table 2. List of Vendors
Table 3. Point of Care Diagnostics Market – Revenue, 2021- 2024 (US$ Million)
Table 4. Point of Care Diagnostics Market – Revenue, 2025- 2031 (US$ Million)
Table 5. Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Product
Table 6. Point of Care Diagnostics Market – Revenue, 2025 - 2031(US$ Million) – by Product
Table 7. Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Purchase Mode
Table 8. Point of Care Diagnostics Market – Revenue, 2025 - 2031(US$ Million) – by Purchase Mode
Table 9. Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Sample
Table 10. Point of Care Diagnostics Market – Revenue, 2025 - 2031(US$ Million) – by Sample
Table 11. Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by End User
Table 12. Point of Care Diagnostics Market – Revenue, 2025 - 2031(US$ Million) – by End User
Table 13. North America: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Product
Table 14. North America: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Product
Table 15. North America: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Glucose Monitoring
Table 16. North America: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Glucose Monitoring
Table 17. North America: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Infectious Disease Testing
Table 18. North America: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Infectious Disease Testing
Table 19. North America: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Cardio Metabolic Testing
Table 20. North America: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Cardio Metabolic Testing
Table 21. North America: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Purchase Mode
Table 22. North America: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Purchase Mode
Table 23. North America: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Sample
Table 24. North America: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Sample
Table 25. North America: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by End User
Table 26. North America: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by End User
Table 27. North America: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Healthcare Facilities
Table 28. North America: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Healthcare Facilities
Table 29. North America: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Country
Table 30. North America: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Country
Table 31. United States: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Product
Table 32. United States: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Product
Table 33. United States: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Glucose Monitoring
Table 34. United States: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Glucose Monitoring
Table 35. United States: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Infectious Disease Testing
Table 36. United States: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Infectious Disease Testing
Table 37. United States: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Cardio Metabolic Testing
Table 38. United States: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Cardio Metabolic Testing
Table 39. United States: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Purchase Mode
Table 40. United States: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Purchase Mode
Table 41. United States: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Sample
Table 42. United States: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Sample
Table 43. United States: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by End User
Table 44. United States: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by End User
Table 45. United States: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Healthcare Facilities
Table 46. United States: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Healthcare Facilities
Table 47. Canada: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Product
Table 48. Canada: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Product
Table 49. Canada: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Glucose Monitoring
Table 50. Canada: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Glucose Monitoring
Table 51. Canada: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Infectious Disease Testing
Table 52. Canada: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Infectious Disease Testing
Table 53. Canada: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Cardio Metabolic Testing
Table 54. Canada: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Cardio Metabolic Testing
Table 55. Canada: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Purchase Mode
Table 56. Canada: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Purchase Mode
Table 57. Canada: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Sample
Table 58. Canada: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Sample
Table 59. Canada: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by End User
Table 60. Canada: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by End User
Table 61. Canada: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Healthcare Facilities
Table 62. Canada: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Healthcare Facilities
Table 63. Mexico: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Product
Table 64. Mexico: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Product
Table 65. Mexico: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Glucose Monitoring
Table 66. Mexico: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Glucose Monitoring
Table 67. Mexico: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Infectious Disease Testing
Table 68. Mexico: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Infectious Disease Testing
Table 69. Mexico: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Cardio Metabolic Testing
Table 70. Mexico: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Cardio Metabolic Testing
Table 71. Mexico: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Purchase Mode
Table 72. Mexico: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Purchase Mode
Table 73. Mexico: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Sample
Table 74. Mexico: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Sample
Table 75. Mexico: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by End User
Table 76. Mexico: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by End User
Table 77. Mexico: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Healthcare Facilities
Table 78. Mexico: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Healthcare Facilities
Table 79. Europe: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Product
Table 80. Europe: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Product
Table 81. Europe: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Glucose Monitoring
Table 82. Europe: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Glucose Monitoring
Table 83. Europe: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Infectious Disease Testing
Table 84. Europe: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Infectious Disease Testing
Table 85. Europe: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Cardio Metabolic Testing
Table 86. Europe: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Cardio Metabolic Testing
Table 87. Europe: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Purchase Mode
Table 88. Europe: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Purchase Mode
Table 89. Europe: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Sample
Table 90. Europe: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Sample
Table 91. Europe: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by End User
Table 92. Europe: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by End User
Table 93. Europe: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Healthcare Facilities
Table 94. Europe: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Healthcare Facilities
Table 95. Europe: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Country
Table 96. Europe: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Country
Table 97. United Kingdom: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Product
Table 98. United Kingdom: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Product
Table 99. United Kingdom: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Glucose Monitoring
Table 100. United Kingdom: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Glucose Monitoring
Table 101. United Kingdom: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Infectious Disease Testing
Table 102. United Kingdom: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Infectious Disease Testing
Table 103. United Kingdom: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Cardio Metabolic Testing
Table 104. United Kingdom: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Cardio Metabolic Testing
Table 105. United Kingdom: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Purchase Mode
Table 106. United Kingdom: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Purchase Mode
Table 107. United Kingdom: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Sample
Table 108. United Kingdom: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Sample
Table 109. United Kingdom: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by End User
Table 110. United Kingdom: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by End User
Table 111. United Kingdom: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Healthcare Facilities
Table 112. United Kingdom: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Healthcare Facilities
Table 113. Germany: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Product
Table 114. Germany: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Product
Table 115. Germany: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Glucose Monitoring
Table 116. Germany: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Glucose Monitoring
Table 117. Germany: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Infectious Disease Testing
Table 118. Germany: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Infectious Disease Testing
Table 119. Germany: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Cardio Metabolic Testing
Table 120. Germany: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Cardio Metabolic Testing
Table 121. Germany: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Purchase Mode
Table 122. Germany: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Purchase Mode
Table 123. Germany: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Sample
Table 124. Germany: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Sample
Table 125. Germany: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by End User
Table 126. Germany: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by End User
Table 127. Germany: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Healthcare Facilities
Table 128. Germany: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Healthcare Facilities
Table 129. France: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Product
Table 130. France: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Product
Table 131. France: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Glucose Monitoring
Table 132. France: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Glucose Monitoring
Table 133. France: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Infectious Disease Testing
Table 134. France: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Infectious Disease Testing
Table 135. France: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Cardio Metabolic Testing
Table 136. France: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Cardio Metabolic Testing
Table 137. France: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Purchase Mode
Table 138. France: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Purchase Mode
Table 139. France: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Sample
Table 140. France: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Sample
Table 141. France: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by End User
Table 142. France: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by End User
Table 143. France: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Healthcare Facilities
Table 144. France: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Healthcare Facilities
Table 145. Italy: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Product
Table 146. Italy: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Product
Table 147. Italy: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Glucose Monitoring
Table 148. Italy: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Glucose Monitoring
Table 149. Italy: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Infectious Disease Testing
Table 150. Italy: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Infectious Disease Testing
Table 151. Italy: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Cardio Metabolic Testing
Table 152. Italy: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Cardio Metabolic Testing
Table 153. Italy: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Purchase Mode
Table 154. Italy: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Purchase Mode
Table 155. Italy: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Sample
Table 156. Italy: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Sample
Table 157. Italy: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by End User
Table 158. Italy: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by End User
Table 159. Italy: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Healthcare Facilities
Table 160. Italy: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Healthcare Facilities
Table 161. Spain: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Product
Table 162. Spain: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Product
Table 163. Spain: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Glucose Monitoring
Table 164. Spain: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Glucose Monitoring
Table 165. Spain: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Infectious Disease Testing
Table 166. Spain: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Infectious Disease Testing
Table 167. Spain: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Cardio Metabolic Testing
Table 168. Spain: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Cardio Metabolic Testing
Table 169. Spain: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Purchase Mode
Table 170. Spain: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Purchase Mode
Table 171. Spain: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Sample
Table 172. Spain: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Sample
Table 173. Spain: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by End User
Table 174. Spain: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by End User
Table 175. Spain: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Healthcare Facilities
Table 176. Spain: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Healthcare Facilities
Table 177. Rest of Europe: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Product
Table 178. Rest of Europe: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Product
Table 179. Rest of Europe: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Glucose Monitoring
Table 180. Rest of Europe: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Glucose Monitoring
Table 181. Rest of Europe: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Infectious Disease Testing
Table 182. Rest of Europe: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Infectious Disease Testing
Table 183. Rest of Europe: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Cardio Metabolic Testing
Table 184. Rest of Europe: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Cardio Metabolic Testing
Table 185. Rest of Europe: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Purchase Mode
Table 186. Rest of Europe: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Purchase Mode
Table 187. Rest of Europe: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Sample
Table 188. Rest of Europe: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Sample
Table 189. Rest of Europe: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by End User
Table 190. Rest of Europe: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by End User
Table 191. Rest of Europe: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Healthcare Facilities
Table 192. Rest of Europe: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Healthcare Facilities
Table 193. Asia Pacific: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Product
Table 194. Asia Pacific: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Product
Table 195. Asia Pacific: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Glucose Monitoring
Table 196. Asia Pacific: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Glucose Monitoring
Table 197. Asia Pacific: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Infectious Disease Testing
Table 198. Asia Pacific: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Infectious Disease Testing
Table 199. Asia Pacific: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Cardio Metabolic Testing
Table 200. Asia Pacific: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Cardio Metabolic Testing
Table 201. Asia Pacific: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Purchase Mode
Table 202. Asia Pacific: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Purchase Mode
Table 203. Asia Pacific: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Sample
Table 204. Asia Pacific: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Sample
Table 205. Asia Pacific: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by End User
Table 206. Asia Pacific: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by End User
Table 207. Asia Pacific: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Healthcare Facilities
Table 208. Asia Pacific: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Healthcare Facilities
Table 209. Asia Pacific: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Country
Table 210. Asia Pacific: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Country
Table 211. China: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Product
Table 212. China: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Product
Table 213. China: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Glucose Monitoring
Table 214. China: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Glucose Monitoring
Table 215. China: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Infectious Disease Testing
Table 216. China: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Infectious Disease Testing
Table 217. China: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Cardio Metabolic Testing
Table 218. China: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Cardio Metabolic Testing
Table 219. China: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Purchase Mode
Table 220. China: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Purchase Mode
Table 221. China: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Sample
Table 222. China: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Sample
Table 223. China: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by End User
Table 224. China: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by End User
Table 225. China: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Healthcare Facilities
Table 226. China: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Healthcare Facilities
Table 227. Japan: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Product
Table 228. Japan: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Product
Table 229. Japan: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Glucose Monitoring
Table 230. Japan: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Glucose Monitoring
Table 231. Japan: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Infectious Disease Testing
Table 232. Japan: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Infectious Disease Testing
Table 233. Japan: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Cardio Metabolic Testing
Table 234. Japan: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Cardio Metabolic Testing
Table 235. Japan: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Purchase Mode
Table 236. Japan: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Purchase Mode
Table 237. Japan: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Sample
Table 238. Japan: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Sample
Table 239. Japan: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by End User
Table 240. Japan: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by End User
Table 241. Japan: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Healthcare Facilities
Table 242. Japan: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Healthcare Facilities
Table 243. India: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Product
Table 244. India: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Product
Table 245. India: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Glucose Monitoring
Table 246. India: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Glucose Monitoring
Table 247. India: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Infectious Disease Testing
Table 248. India: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Infectious Disease Testing
Table 249. India: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Cardio Metabolic Testing
Table 250. India: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Cardio Metabolic Testing
Table 251. India: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Purchase Mode
Table 252. India: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Purchase Mode
Table 253. India: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Sample
Table 254. India: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Sample
Table 255. India: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by End User
Table 256. India: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by End User
Table 257. India: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Healthcare Facilities
Table 258. India: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Healthcare Facilities
Table 259. Australia: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Product
Table 260. Australia: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Product
Table 261. Australia: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Glucose Monitoring
Table 262. Australia: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Glucose Monitoring
Table 263. Australia: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Infectious Disease Testing
Table 264. Australia: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Infectious Disease Testing
Table 265. Australia: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Cardio Metabolic Testing
Table 266. Australia: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Cardio Metabolic Testing
Table 267. Australia: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Purchase Mode
Table 268. Australia: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Purchase Mode
Table 269. Australia: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Sample
Table 270. Australia: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Sample
Table 271. Australia: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by End User
Table 272. Australia: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by End User
Table 273. Australia: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Healthcare Facilities
Table 274. Australia: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Healthcare Facilities
Table 275. South Korea: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Product
Table 276. South Korea: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Product
Table 277. South Korea: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Glucose Monitoring
Table 278. South Korea: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Glucose Monitoring
Table 279. South Korea: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Infectious Disease Testing
Table 280. South Korea: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Infectious Disease Testing
Table 281. South Korea: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Cardio Metabolic Testing
Table 282. South Korea: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Cardio Metabolic Testing
Table 283. South Korea: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Purchase Mode
Table 284. South Korea: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Purchase Mode
Table 285. South Korea: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Sample
Table 286. South Korea: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Sample
Table 287. South Korea: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by End User
Table 288. South Korea: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by End User
Table 289. South Korea: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Healthcare Facilities
Table 290. South Korea: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Healthcare Facilities
Table 291. Rest of APAC: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Product
Table 292. Rest of APAC: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Product
Table 293. Rest of APAC: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Glucose Monitoring
Table 294. Rest of APAC: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Glucose Monitoring
Table 295. Rest of APAC: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Infectious Disease Testing
Table 296. Rest of APAC: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Infectious Disease Testing
Table 297. Rest of APAC: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Cardio Metabolic Testing
Table 298. Rest of APAC: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Cardio Metabolic Testing
Table 299. Rest of APAC: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Purchase Mode
Table 300. Rest of APAC: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Purchase Mode
Table 301. Rest of APAC: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Sample
Table 302. Rest of APAC: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Sample
Table 303. Rest of APAC: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by End User
Table 304. Rest of APAC: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by End User
Table 305. Rest of APAC: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Healthcare Facilities
Table 306. Rest of APAC: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Healthcare Facilities
Table 307. Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Product
Table 308. Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Product
Table 309. Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Glucose Monitoring
Table 310. Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Glucose Monitoring
Table 311. Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Infectious Disease Testing
Table 312. Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Infectious Disease Testing
Table 313. Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Cardio Metabolic Testing
Table 314. Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Cardio Metabolic Testing
Table 315. Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Purchase Mode
Table 316. Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Purchase Mode
Table 317. Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Sample
Table 318. Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Sample
Table 319. Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by End User
Table 320. Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by End User
Table 321. Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Healthcare Facilities
Table 322. Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Healthcare Facilities
Table 323. Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Country
Table 324. Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Country
Table 325. South Africa: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Product
Table 326. South Africa: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Product
Table 327. South Africa: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Glucose Monitoring
Table 328. South Africa: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Glucose Monitoring
Table 329. South Africa: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Infectious Disease Testing
Table 330. South Africa: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Infectious Disease Testing
Table 331. South Africa: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Cardio Metabolic Testing
Table 332. South Africa: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Cardio Metabolic Testing
Table 333. South Africa: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Purchase Mode
Table 334. South Africa: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Purchase Mode
Table 335. South Africa: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Sample
Table 336. South Africa: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Sample
Table 337. South Africa: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by End User
Table 338. South Africa: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by End User
Table 339. South Africa: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Healthcare Facilities
Table 340. South Africa: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Healthcare Facilities
Table 341. Saudi Arabia: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Product
Table 342. Saudi Arabia: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Product
Table 343. Saudi Arabia: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Glucose Monitoring
Table 344. Saudi Arabia: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Glucose Monitoring
Table 345. Saudi Arabia: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Infectious Disease Testing
Table 346. Saudi Arabia: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Infectious Disease Testing
Table 347. Saudi Arabia: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Cardio Metabolic Testing
Table 348. Saudi Arabia: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Cardio Metabolic Testing
Table 349. Saudi Arabia: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Purchase Mode
Table 350. Saudi Arabia: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Purchase Mode
Table 351. Saudi Arabia: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Sample
Table 352. Saudi Arabia: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Sample
Table 353. Saudi Arabia: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by End User
Table 354. Saudi Arabia: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by End User
Table 355. Saudi Arabia: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Healthcare Facilities
Table 356. Saudi Arabia: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Healthcare Facilities
Table 357. United Arab Emirates: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Product
Table 358. United Arab Emirates: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Product
Table 359. United Arab Emirates: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Glucose Monitoring
Table 360. United Arab Emirates: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Glucose Monitoring
Table 361. United Arab Emirates: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Infectious Disease Testing
Table 362. United Arab Emirates: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Infectious Disease Testing
Table 363. United Arab Emirates: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Cardio Metabolic Testing
Table 364. United Arab Emirates: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Cardio Metabolic Testing
Table 365. United Arab Emirates: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Purchase Mode
Table 366. United Arab Emirates: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Purchase Mode
Table 367. United Arab Emirates: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Sample
Table 368. United Arab Emirates: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Sample
Table 369. United Arab Emirates: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by End User
Table 370. United Arab Emirates: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by End User
Table 371. United Arab Emirates: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Healthcare Facilities
Table 372. United Arab Emirates: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Healthcare Facilities
Table 373. Rest of Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Product
Table 374. Rest of Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Product
Table 375. Rest of Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Glucose Monitoring
Table 376. Rest of Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Glucose Monitoring
Table 377. Rest of Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Infectious Disease Testing
Table 378. Rest of Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Infectious Disease Testing
Table 379. Rest of Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Cardio Metabolic Testing
Table 380. Rest of Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Cardio Metabolic Testing
Table 381. Rest of Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Purchase Mode
Table 382. Rest of Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Purchase Mode
Table 383. Rest of Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Sample
Table 384. Rest of Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Sample
Table 385. Rest of Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by End User
Table 386. Rest of Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by End User
Table 387. Rest of Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Healthcare Facilities
Table 388. Rest of Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Healthcare Facilities
Table 389. South and Central America: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Product
Table 390. South and Central America: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Product
Table 391. South and Central America: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Glucose Monitoring
Table 392. South and Central America: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Glucose Monitoring
Table 393. South and Central America: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Infectious Disease Testing
Table 394. South and Central America: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Infectious Disease Testing
Table 395. South and Central America: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Cardio Metabolic Testing
Table 396. South and Central America: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Cardio Metabolic Testing
Table 397. South and Central America: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Purchase Mode
Table 398. South and Central America: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Purchase Mode
Table 399. South and Central America: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Sample
Table 400. South and Central America: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Sample
Table 401. South and Central America: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by End User
Table 402. South and Central America: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by End User
Table 403. South and Central America: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Healthcare Facilities
Table 404. South and Central America: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Healthcare Facilities
Table 405. South and Central America: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Country
Table 406. South and Central America: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Country
Table 407. Brazil: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Product
Table 408. Brazil: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Product
Table 409. Brazil: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Glucose Monitoring
Table 410. Brazil: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Glucose Monitoring
Table 411. Brazil: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Infectious Disease Testing
Table 412. Brazil: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Infectious Disease Testing
Table 413. Brazil: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Cardio Metabolic Testing
Table 414. Brazil: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Cardio Metabolic Testing
Table 415. Brazil: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Purchase Mode
Table 416. Brazil: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Purchase Mode
Table 417. Brazil: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Sample
Table 418. Brazil: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Sample
Table 419. Brazil: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by End User
Table 420. Brazil: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by End User
Table 421. Brazil: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Healthcare Facilities
Table 422. Brazil: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Healthcare Facilities
Table 423. Argentina: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Product
Table 424. Argentina: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Product
Table 425. Argentina: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Glucose Monitoring
Table 426. Argentina: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Glucose Monitoring
Table 427. Argentina: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Infectious Disease Testing
Table 428. Argentina: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Infectious Disease Testing
Table 429. Argentina: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Cardio Metabolic Testing
Table 430. Argentina: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Cardio Metabolic Testing
Table 431. Argentina: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Purchase Mode
Table 432. Argentina: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Purchase Mode
Table 433. Argentina: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Sample
Table 434. Argentina: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Sample
Table 435. Argentina: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by End User
Table 436. Argentina: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by End User
Table 437. Argentina: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Healthcare Facilities
Table 438. Argentina: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Healthcare Facilities
Table 439. Rest of South and Central America: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Product
Table 440. Rest of South and Central America: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Product
Table 441. Rest of South and Central America: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Glucose Monitoring
Table 442. Rest of South and Central America: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Glucose Monitoring
Table 443. Rest of South and Central America: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Infectious Disease Testing
Table 444. Rest of South and Central America: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Infectious Disease Testing
Table 445. Rest of South and Central America: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Cardio Metabolic Testing
Table 446. Rest of South and Central America: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Cardio Metabolic Testing
Table 447. Rest of South and Central America: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Purchase Mode
Table 448. Rest of South and Central America: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Purchase Mode
Table 449. Rest of South and Central America: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Sample
Table 450. Rest of South and Central America: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Sample
Table 451. Rest of South and Central America: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by End User
Table 452. Rest of South and Central America: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by End User
Table 453. Rest of South and Central America: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Healthcare Facilities
Table 454. Rest of South and Central America: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Healthcare Facilities
Table 455. Heat Map Analysis by Key Players
List of Figures
Figure 1. Point of Care Diagnostics Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Point of Care Diagnostics Market Revenue (US$ Million), 2021–2031
Figure 5. Point of Care Diagnostics Market Share (%) – by Product (2024 and 2031)
Figure 6. Glucose Monitoring: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
Figure 7. Infectious Disease Testing: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
Figure 8. Cardio metabolic Testing: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
Figure 9. Pregnancy And Fertility Testing: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
Figure 10. Coagulation Testing: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
Figure 11. Tumor or Cancer Marker Testing: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
Figure 12. Cholesterol Testing: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
Figure 13. Urinalysis Testing: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
Figure 14. Hematology Testing: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
Figure 15. Thyroid Testing: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
Figure 16. Others: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
Figure 17. Point of Care Diagnostics Market Share (%) – by Purchase Mode (2024 and 2031)
Figure 18. OTC: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
Figure 19. Prescription: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
Figure 20. Point of Care Diagnostics Market Share (%) – by Sample (2024 and 2031)
Figure 21. Blood: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
Figure 22. Urine: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
Figure 23. Others: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
Figure 24. Point of Care Diagnostics Market Share (%) – by End User (2024 and 2031)
Figure 25. Healthcare Facilities: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
Figure 26. Homecare: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
Figure 27. Others: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
Figure 28. Point of Care Diagnostics Market Breakdown by Region, 2024 and 2031 (%)
Figure 29. North America: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)
Figure 30. North America: Point of Care Diagnostics Market Breakdown, by Product (2024 and 2031)
Figure 31. North America: Point of Care Diagnostics Market Breakdown, by Purchase Mode (2024 and 2031)
Figure 32. North America: Point of Care Diagnostics Market Breakdown, by Sample (2024 and 2031)
Figure 33. North America: Point of Care Diagnostics Market Breakdown, by End User (2024 and 2031)
Figure 34. North America: Point of Care Diagnostics Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 35. United States: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)
Figure 36. Canada: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)
Figure 37. Mexico: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)
Figure 38. Europe: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)
Figure 39. Europe: Point of Care Diagnostics Market Breakdown, by Product (2024 and 2031)
Figure 40. Europe: Point of Care Diagnostics Market Breakdown, by Purchase Mode (2024 and 2031)
Figure 41. Europe: Point of Care Diagnostics Market Breakdown, by Sample (2024 and 2031)
Figure 42. Europe: Point of Care Diagnostics Market Breakdown, by End User (2024 and 2031)
Figure 43. Europe: Point of Care Diagnostics Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 44. United Kingdom: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)
Figure 45. Germany: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)
Figure 46. France: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)
Figure 47. Italy: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)
Figure 48. Spain: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)
Figure 49. Rest of Europe: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)
Figure 50. Asia Pacific: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)
Figure 51. Asia Pacific: Point of Care Diagnostics Market Breakdown, by Product (2024 and 2031)
Figure 52. Asia Pacific: Point of Care Diagnostics Market Breakdown, by Purchase Mode (2024 and 2031)
Figure 53. Asia Pacific: Point of Care Diagnostics Market Breakdown, by Sample (2024 and 2031)
Figure 54. Asia Pacific: Point of Care Diagnostics Market Breakdown, by End User (2024 and 2031)
Figure 55. Asia Pacific: Point of Care Diagnostics Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 56. China: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)
Figure 57. Japan: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)
Figure 58. India: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)
Figure 59. Australia: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)
Figure 60. South Korea: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)
Figure 61. Rest of APAC: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)
Figure 62. Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)
Figure 63. Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Product (2024 and 2031)
Figure 64. Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Purchase Mode (2024 and 2031)
Figure 65. Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Sample (2024 and 2031)
Figure 66. Middle East and Africa: Point of Care Diagnostics Market Breakdown, by End User (2024 and 2031)
Figure 67. Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 68. South Africa: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)
Figure 69. Saudi Arabia: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)
Figure 70. United Arab Emirates: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)
Figure 71. Rest of Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)
Figure 72. South and Central America: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)
Figure 73. South and Central America: Point of Care Diagnostics Market Breakdown, by Product (2024 and 2031)
Figure 74. South and Central America: Point of Care Diagnostics Market Breakdown, by Purchase Mode (2024 and 2031)
Figure 75. South and Central America: Point of Care Diagnostics Market Breakdown, by Sample (2024 and 2031)
Figure 76. South and Central America: Point of Care Diagnostics Market Breakdown, by End User (2024 and 2031)
Figure 77. South and Central America: Point of Care Diagnostics Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 78. Brazil: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)
Figure 79. Argentina: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)
Figure 80. Rest of South and Central America: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)
Figure 81. Company Market Share Analysis, 2024
The List of Companies - Point of Care Diagnostics Market
- F. Hoffmann-La Roche Ltd
- Bio-Rad Laboratories Inc
- Abbott Laboratories
- QIAGEN NV
- Siemens AG
- BD
- bioMerieux SA
- Polymer Technology Systems, Inc. (PTS)
- Nova Biomedical Corporation
- Danaher Corp
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Point of Care Diagnostics Market

May 2025
Wound Closure Devices Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Sutures, Adhesives, Staplers, Strips, and Others), Wound Type (Chronic Wound and Acute Wound), End User (Hospitals, Clinics, Ambulatory Surgery Centers, and Others), and Geography

May 2025
Pediatric Cardiology Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Transcatheter Heart Valves, Occlusion Devices, Catheters, Stents, Introducer Sheaths, and Others), Disease Indication (Congenital Heart Disease, Acquired Heart Disease, Arrhythmias, Cardiomyopathies, and Others), Surgical Procedure (Interventional Procedures, Heart Rhythm Management Procedures, and Others), End User (Hospitals, Specialty Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)

May 2025
Pharmaceutical Membrane Filters Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Microfiltration, Ultrafiltration, Reverse Osmosis and Nanofiltration), Design (Hollow Fiber, Spiral Wound, Tubular System and Plate and Frame), Material (Polyethersulfone (PES), Polysulfone (PS), Cellulose-Based Membranes, Polytetrafluoroethylene (PTFE), Polyvinyl Chloride (PVC), Polyacrylonitrile (PAN) and Others), End User (Pharmaceutical and Biotech Industries and CROs and CDMOs), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, South & Central America)

May 2025
ECG Devices Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Resting ECG and Stress ECG), Lead Type (12-Lead ECG, 3–6 Lead ECG, and Single Lead), Technology [Portable (Wired) ECG System and Wireless ECG System], End User (Hospital and Clinics, Ambulatory Surgical Centers, Cardiac Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)

May 2025
Surgical Laser Fiber Units Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Laser Type (CO2 Laser, Diode Laser, Erbium Laser, Nd:YAG Laser, Holmium Laser, Alexandrite Laser, and Others), Material (Silica-Based Fibers, Quartz Fibers, Polymer-Based Fibers, Multimode Fibers, and Others), Power (Low-Power Lasers, Medium-Power Lasers, and High-Power Lasers), Application (Urology, Dermatology, Gynecology, Cardiology, Neurology, Ophthalmology, Respiratory, Dentistry and Others), Wavelength (9,301 nm and above, 2,941–9,300 nm, and 1,441–2,940 nm, 821–1,440 nm, 710–820 nm, and below 710 nm), End User (Hospitals, Specialty Clinics, Physician Office, and Others), and Geography

May 2025
Therapeutic Vaccines Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Cancer Vaccines, Infectious Disease Vaccines, and Others), Technology (Allogenic Vaccines and Autologous Vaccines), End User (Hospitals, Clinics, and Others), and Geography

May 2025
Medical Cables Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Disposable Medical Cables, Reusable Medical Cables, and Custom Medical Cables), Applications [Diagnostics (Ultrasound Cables, Endoscopy Cables, Patient Interface Cables, and Others), Motorized Equipment, Patient Monitoring (ECG Cables, SpO2 Cables, NiBP Cables, EEG Cables, and Others), Surgical and Life Support (Fiber Optics, Modular Local Area Network, and Others), and Others], End User (Hospital and Clinics, Diagnostic Laboratories and Imaging Centers, Ambulatory Surgical Centers, and Others), and Geography

May 2025
Laser-Assisted ENT Surgeries Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Laser Type (C02 Laser, Nd:YAG Laser, Diode Laser, Blue Laser, KTP Laser, Argon Laser, and Other Laser Types), Surgery Type [Laser Laryngeal Surgery, Laser Endoscopic Sinus Surgery (LESS), Laser-Assisted Uvulopalatoplasty (LAUP), Laser-Assisted Stapedotomy, Laser-Assisted Tonsillectomy and Adenoidectomy, Laser Turbinates Reduction, Transoral Laser Microsurgery (TLM), Nasal Surgery, and Other Surgery Types], End User (Hospitals and Specialty Clinics, Physician Offices, and Other End Users), and Geography (North America, Europe, Asia Pacific, South and Central America, and Middle East and Africa)